These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 1314754)

  • 1. Omeprazole, cytochrome P450, and chemical carcinogenesis.
    Lucier GW; Thompson CL; Hoel DG
    Gastroenterology; 1992 May; 102(5):1823-4. PubMed ID: 1314754
    [No Abstract]   [Full Text] [Related]  

  • 2. Omeprazole is an aryl hydrocarbon-like inducer of human hepatic cytochrome P450.
    Diaz D; Fabre I; Daujat M; Saint Aubert B; Bories P; Michel H; Maurel P
    Gastroenterology; 1990 Sep; 99(3):737-47. PubMed ID: 2136526
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Review article: omeprazole and the cytochrome P450 system.
    Petersen KU
    Aliment Pharmacol Ther; 1995 Feb; 9(1):1-9. PubMed ID: 7766737
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human cytochrome P450 isoforms. Their genetic heterogeneity and induction by omeprazole.
    Farrell GC; Murray M
    Gastroenterology; 1990 Sep; 99(3):885-9. PubMed ID: 2199294
    [No Abstract]   [Full Text] [Related]  

  • 5. Nuclear uptake of the Ah (dioxin) receptor in response to omeprazole: transcriptional activation of the human CYP1A1 gene.
    Quattrochi LC; Tukey RH
    Mol Pharmacol; 1993 Apr; 43(4):504-8. PubMed ID: 8386305
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Omeprazole, an inducer of human CYP1A1 and 1A2, is not a ligand for the Ah receptor.
    Daujat M; Peryt B; Lesca P; Fourtanier G; Domergue J; Maurel P
    Biochem Biophys Res Commun; 1992 Oct; 188(2):820-5. PubMed ID: 1280125
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Omeprazole and lansoprazole are mixed inducers of CYP1A and CYP3A in human hepatocytes in primary culture.
    Curi-Pedrosa R; Daujat M; Pichard L; Ourlin JC; Clair P; Gervot L; Lesca P; Domergue J; Joyeux H; Fourtanier G
    J Pharmacol Exp Ther; 1994 Apr; 269(1):384-92. PubMed ID: 8169844
    [TBL] [Abstract][Full Text] [Related]  

  • 8. P450IA2 and omeprazole.
    Farrell G
    Gastroenterology; 1992 May; 102(5):1822-3. PubMed ID: 1345326
    [No Abstract]   [Full Text] [Related]  

  • 9. Dose dependent induction of CYP1A2 activity by omeprazole (Antra).
    Rost KL; Brösicke H; Scheffler M; Roots I
    Int J Clin Pharmacol Ther Toxicol; 1992 Nov; 30(11):542-3. PubMed ID: 1490825
    [No Abstract]   [Full Text] [Related]  

  • 10. Omeprazole and aryl hydrocarbon hydroxylases: should we be worried?
    Kolars JC; Turgeon DK; Watkins PB
    Hepatology; 1991 Jan; 13(1):197-9. PubMed ID: 1988343
    [No Abstract]   [Full Text] [Related]  

  • 11. Regulation of cytochrome P450 genes: molecular mechanisms.
    Gonzalez FJ; Liu SY; Yano M
    Pharmacogenetics; 1993 Feb; 3(1):51-7. PubMed ID: 8387380
    [No Abstract]   [Full Text] [Related]  

  • 12. Different inducibility of cytochrome P-4501A1 mRNA of human and mouse by omeprazole in culture cells.
    Kikuchi H; Hossain A; Sagami I; Ikawa S; Watanabe M
    Arch Biochem Biophys; 1995 Jan; 316(1):649-52. PubMed ID: 7840678
    [No Abstract]   [Full Text] [Related]  

  • 13. Omeprazole induction of cytochrome P-450IA2: the importance of selecting the appropriate human model.
    Watkins PB
    Hepatology; 1993 Apr; 17(4):748-50. PubMed ID: 8477980
    [No Abstract]   [Full Text] [Related]  

  • 14. Induction of cytochrome P450IA1 in mouse hepatoma cells by several chemicals. Phenobarbital and TCDD induce the same form of cytochrome P450.
    Kärenlampi SO; Tuomi K; Korkalainen M; Raunio H
    Biochem Pharmacol; 1989 May; 38(9):1517-25. PubMed ID: 2541728
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induction of cytochrome P450-dependent monooxygenase activities in rat hepatoma H-4-IIE cells in culture by 2,3,7,8-tetrachlorodibenzo-p-dioxin and related compounds: mechanistic studies using radiolabeled congeners.
    Zacharewski T; Harris M; Safe S
    Arch Biochem Biophys; 1989 Aug; 272(2):344-55. PubMed ID: 2546497
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increase of cytochrome P450IA2 activity by omeprazole: evidence by the 13C-[N-3-methyl]-caffeine breath test in poor and extensive metabolizers of S-mephenytoin.
    Rost KL; Brösicke H; Brockmöller J; Scheffler M; Helge H; Roots I
    Clin Pharmacol Ther; 1992 Aug; 52(2):170-80. PubMed ID: 1505152
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative genetic mechanisms of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD)-induced tumors.
    Greenlee WF; Skopek TR; Gaido K; Walker C
    Prog Clin Biol Res; 1990; 331():177-86. PubMed ID: 2156270
    [No Abstract]   [Full Text] [Related]  

  • 18. Characterization of the aryl hydrocarbon receptor and aryl hydrocarbon responsiveness in human ovarian carcinoma cell lines.
    Rowlands C; Krishnan V; Wang X; Santostefano M; Safe S; Miller WR; Langdon S
    Cancer Res; 1993 Apr; 53(8):1802-7. PubMed ID: 8385571
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effects of TCDD on receptors for epidermal growth factor, glucocorticoid, and estrogen in Ah-responsive and -nonresponsive congenic mice and the effects of TCDD on estradiol metabolism in a liver tumor promotion model in female rats.
    Goldstein JA; Lin FH; Stohs SJ; Graham M; Clarke G; Birnbaum L; Lucier G
    Prog Clin Biol Res; 1990; 331():187-202. PubMed ID: 2156271
    [No Abstract]   [Full Text] [Related]  

  • 20. [Omeprazole and the cytochrome P450 system of the liver].
    Petersen KU
    Leber Magen Darm; 1993 Sep; 23(5):186-92. PubMed ID: 8412467
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.